Vaccine developer Sinergium to share bird flu vaccine data globally: WHO

Q: How long will it take to read this news story?

The story "Vaccine developer Sinergium to share bird flu vaccine data globally: WHO" has 500 words across 16 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Vaccine developer Sinergium to share bird flu vaccine data globally: WHO" was covered 5 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 245 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21821554</li><li>URL: https://beamstart.com/news/vaccine-developer-sinergium-to-share-1722244508811</li></ul>

Business Standard Logo Business Standard 5h ago

Vaccine developer Sinergium to share bird flu vaccine data globally: WHO - Business Standard

Quick Summary:

The South African centre was set up after global pharmaceuticals companies including Moderna and Pfizer (PFE.

Sinergium's mRNA flu vaccine has yet to be tested in people, the WHO said, so it would require human trials before use.

While the WHO has said the risk to the public from the avian influenza virus remains low and that it is not spreading between people, they say it has the potential to cause a future pandemic because of its widespread circulation in animals.